✦ LIBER ✦

Patient Preferences in the Choice of Disease Modifying Drugs for Multiple Sclerosis

✍ Scribed by Bergmann, A.; Lang, M.; Bischoff, C.; Schicklmaier, P.; Schiffhorst, G.; Nolting, H.D.; Rellecke, J.; Kunz, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postmarketing evidence of disease-modify

✍ Maria Trojano; Damiano Paolicelli; Aurora Fuiani; Fabio Pellegrini; Pietro Iaffa 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 33 KB

Disease-modifying drugs for multiple scl

✍ Lu, E.; Wang, B. W.; Guimond, C.; Synnes, A.; Sadovnick, D.; Tremlett, H. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 252 KB

Disease-modifying drugs in multiple scle

✍ B. Bailey 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 193 KB

PND21 FIRST USE OF DISEASE-MODIFYING DRU

✍ DM Meletiche; C Kozma; M Dickson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Patient preferences for attributes of di

✍ Wilson, L.S.; Loucks, A.; Bui, C.T.; Gipson, G.; Zhong, L.; Tang, J.; Goodin, D. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PND45 USE OF DISEASE-MODIFYING DRUGS IN

✍ K Noyes; A Bajorska; S Schwid; R Holloway; A Dick 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB